NASDAQ: CELZ
Creative Medical Technology Holdings Inc Stock Ownership - Who owns Creative Medical Technology Holdings?

Insider buying vs selling

Have Creative Medical Technology Holdings Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CELZ insiders and whales buy or sell their stock.

CELZ Shareholders

What type of owners hold Creative Medical Technology Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Geode Capital Management LLC1.04%38,290$85.39kInstitution
Timothy Warbington0.94%34,904$77.84kInsider
Vanguard Capital Management LLC0.55%20,350$45.38kInstitution
Xtx Topco Ltd0.39%14,260$31.80kInstitution
Susquehanna International Group LLP0.28%10,469$23.35kInstitution
Vanguard Fiduciary Trust Co0.15%5,518$12.31kInstitution
Wells Fargo Company0.14%5,000$11.15kInstitution
Tower Research Capital LLC Trc0.06%2,092$4.67kInstitution
Morgan Stanley0.01%534$1.19kInstitution
Michael H. Finger0.01%351$782.73Insider

1 of 2

CELZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CELZ2.62%0.95%
ACXP4.23%59.85%
IMRN0.03%1.91%
ELAB0.27%99.73%
ADXN0.00%15.05%

Creative Medical Technology Holdings Stock Ownership FAQ

Who owns Creative Medical Technology Holdings?

Creative Medical Technology Holdings (NASDAQ: CELZ) is owned by 2.62% institutional shareholders, 0.95% Creative Medical Technology Holdings insiders, and 96.43% retail investors. Timothy Warbington is the largest individual Creative Medical Technology Holdings shareholder, owning 34,904.00 shares representing 0.94% of the company. Timothy Warbington's Creative Medical Technology Holdings shares are currently valued at $76.44k.

If you're new to stock investing, here's how to buy Creative Medical Technology Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.